Tekamlo (aliskiren/amlodipine) / Novartis  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekamlo (aliskiren/amlodipine) / Novartis
NCT00417170: Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome

Completed
2
48
US
Aliskiren, Amlodipine, Placebo Aliskiren, Placebo Amlodipine
Novartis Pharmaceuticals
High Blood Pressure, Metabolic Syndrome, Insulin Resistance, Endothelial Dysfunction
07/10
07/10
NCT01080768 / 2009-014359-63: Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

Terminated
2
31
Europe
Aliskiren/amlodipine, SPA100, Amlodipine, Placebo to Aliskiren/amlodipine, Placebo to Amlodipine
Novartis Pharmaceuticals
Hypertension, Ankle Edema
11/10
11/10
NCT00498433 / 2005-004566-16: Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

Terminated
2
46
Europe
Aliskiren, SPP100, Amlodipine, Placebo of Aliskiren, Placebo of amlodipine
Novartis
Hypertension, Abdominal Obesity
03/12
03/12

Download Options